A.R.T. Advisors, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 134 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$20,000
-90.9%
10,799
-90.8%
0.03%
+172.7%
Q3 2019$220,000
-48.8%
117,577
-28.6%
0.01%
-54.2%
Q2 2019$430,000
+98.2%
164,677
+95.2%
0.02%
+84.6%
Q1 2019$217,000
-48.3%
84,377
-53.8%
0.01%
-51.9%
Q4 2018$420,000
-28.1%
182,502
+0.3%
0.03%0.0%
Q3 2018$584,000
-51.7%
181,938
-57.4%
0.03%
-44.9%
Q2 2018$1,209,000
+351.1%
427,362
+463.8%
0.05%
+345.5%
Q1 2018$268,000
+587.2%
75,800
+389.0%
0.01%
+450.0%
Q3 2017$39,000
-56.7%
15,500
-53.2%
0.00%
-60.0%
Q2 2017$90,000
-32.8%
33,100
-45.0%
0.01%
-28.6%
Q2 2016$134,000
-44.6%
60,151
-48.5%
0.01%
-36.4%
Q1 2016$242,000
-36.1%
116,784
-6.7%
0.01%
-38.9%
Q4 2015$379,000
+58.6%
125,184
+29.3%
0.02%
+100.0%
Q3 2015$239,000
-33.6%
96,784
-13.5%
0.01%
-25.0%
Q2 2015$360,000
+531.6%
111,884
+345.1%
0.01%
+500.0%
Q4 2014$57,000
+23.9%
25,137
+5.1%
0.00%0.0%
Q3 2014$46,000
-90.1%
23,920
-85.4%
0.00%
-92.0%
Q4 2013$466,000
+11.0%
163,627
+39.5%
0.02%
+8.7%
Q3 2013$420,000
-42.5%
117,327
-46.4%
0.02%
-4.2%
Q2 2013$730,000218,7180.02%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders